Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷 / 01期
关键词：
RADIATION;
D O I：
10.1097/01.JU.0000611500.33954.d2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [31] Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
    Brand, Douglas H.
    Tree, Alison C.
    Ostler, Peter
    van der Voet, Hans
    Loblaw, Andrew
    Chu, William
    Ford, Daniel
    Tolan, Shaun
    Jain, Suneil
    Martin, Alexander
    Staffurth, John
    Camilleri, Philip
    Kancherla, Kiran
    Frew, John
    Chan, Andrew
    Dayes, Ian S.
    Henderson, Daniel
    Brown, Stephanie
    Cruickshank, Clare
    Burnett, Stephanie
    Duffton, Aileen
    Griffin, Clare
    Hinder, Victoria
    Morrison, Kirsty
    Naismith, Olivia
    Hall, Emma
    van As, Nicholas
    LANCET ONCOLOGY, 2019, 20 (11): : 1531 - 1543
  • [32] Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial
    Yadav, Budhi Singh
    Dahiya, Divya
    Gupta, Manish
    Gupta, Ankita
    Oinam, Arun S.
    Khare, Siddhant
    Irrinki, Santhosh
    Robert, Ngangom
    Sakaray, Yashwant Raj
    Nagaraj, Satish S.
    Kumari, Reena
    LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 24
  • [33] Re: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy Following Radical Prostatectomy (TROG 08.03/ANZUP RAVES): A Randomised, Controlled, Phase 3, Non-inferiority Trial
    Goertz, Magdalena
    Hohenfellner, Markus
    EUROPEAN UROLOGY, 2021, 79 (06) : 893 - 894
  • [34] Re: Adjuvant Radiotherapy versus Early Salvage Radiotherapy following Radical Prostatectomy (TROG 08.03/ANZUP RAVES): A Randomised, Controlled, Phase 3, Non-Inferiority Trial
    不详
    JOURNAL OF UROLOGY, 2021, 205 (04): : 1225 - 1226
  • [35] Hypofractionated (HF) Versus Conventional Fractionated (CF) Radiotherapy for Breast Cancer Patients Treated with Breast Conserving Surgery: A Randomized, Phase III, Open-Label, Non-Inferiority Trial
    Wang, S. L.
    Song, Y. W.
    Hu, C.
    Wang, W. H.
    Fang, H.
    Liu, X.
    Ren, H.
    Jin, J.
    Liu, Y. P.
    Liu, J.
    Li, G.
    Du, X. H.
    Tang, Y.
    Jing, H.
    Ma, Y.
    Huang, Z.
    Chen, B.
    Tang, Y.
    Li, N.
    Lu, N. N.
    Qi, S.
    Yang, Y.
    Li, Y. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E18 - E18
  • [36] Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
    Tree, Alison C.
    Ostler, Peter
    van der Voet, Hans
    Chu, William
    Loblaw, Andrew
    Ford, Daniel
    Tolan, Shaun
    Jain, Suneil
    Martin, Alexander
    Staffurth, John
    Armstrong, John
    Camilleri, Philip
    Kancherla, Kiran
    Frew, John
    Chan, Andrew
    Dayes, Ian S.
    Duffton, Aileen
    Brand, Douglas H.
    Henderson, Daniel
    Morrison, Kirsty
    Brown, Stephanie
    Pugh, Julia
    Burnett, Stephanie
    Mahmud, Muneeb
    Hinder, Victoria
    Naismith, Olivia
    Hall, Emma
    van As, Nicholas
    LANCET ONCOLOGY, 2022, 23 (10): : 1308 - 1320
  • [37] HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial
    Yadav, Budhi Singh
    Dahiya, Divya
    Kannan, P.
    Goyal, Shikha
    Laroiya, Ishita
    Irrinki, Santhosh
    Singh, Ngangom Robert
    Sharma, Reena
    TRIALS, 2024, 25 (01)
  • [38] Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
    Coles, Charlotte E.
    Griffin, Clare L.
    Kirby, Anna M.
    Titley, Jenny
    Agrawal, Rajiv K.
    Alhasso, Abdulla
    Bhattacharya, Indrani S.
    Brunt, Adrian M.
    Ciurlionis, Laura
    Chan, Charlie
    Donovan, Ellen M.
    Emson, Marie A.
    Harnett, Adrian N.
    Haviland, Joanne S.
    Hopwood, Penelope
    Jefford, Monica L.
    Kaggwa, Ronald
    Sawyer, Elinor J.
    Syndikus, Isabel
    Tsang, Yat M.
    Wheatley, Duncan A.
    Wilcox, Maggie
    Yarnold, John R.
    Bliss, Judith M.
    LANCET, 2017, 390 (10099): : 1048 - 1060
  • [39] HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial
    Budhi Singh Yadav
    Divya Dahiya
    P. Kannan
    Shikha Goyal
    Ishita Laroiya
    Santhosh Irrinki
    Ngangom Robert Singh
    Reena Sharma
    Trials, 25
  • [40] Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial (vol 376, pg 91, 2010)
    Vaidya, J. S.
    Joseph, D. J.
    Tobias, J. S.
    LANCET, 2010, 376 (9735): : 90 - 90
12345